Clinical hold lifted for late stage cadisegliatin program for diabetesCATT1 Phase 3 trial in patients with type 1 diabetes (T1D) expected to ...
Correction: The below stock market announcement (SMA) is a correction of the SMA published on 20 March 2025 message ID 641734. The reason for the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback